HSCT using peripheral blood stem cells exhibited better recovery of HCMV-specific CD8+ T-cell function 3 months after transplantation compared to patients that received bone marrow stem cells [10], thus supporting that differences in INF-γ production by distinct T-cell subpopulations lead to different HCMV infection rates. This evidence concerns the gene CD8A and cytomegalovirus infection.